ES2112921T3 - Peptidos y anticuerpos para el tratamiento de la artritis reumatoide. - Google Patents
Peptidos y anticuerpos para el tratamiento de la artritis reumatoide.Info
- Publication number
- ES2112921T3 ES2112921T3 ES92923909T ES92923909T ES2112921T3 ES 2112921 T3 ES2112921 T3 ES 2112921T3 ES 92923909 T ES92923909 T ES 92923909T ES 92923909 T ES92923909 T ES 92923909T ES 2112921 T3 ES2112921 T3 ES 2112921T3
- Authority
- ES
- Spain
- Prior art keywords
- peptides
- antibodies
- treatment
- rheumatoid arthritis
- necessarily adjacent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8125—Alpha-1-antitrypsin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Rheumatology (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
UN PEPTIDO SINTETICO DE NO MAS DE 20 RESIDUOS DE AMINOACIDOS O ANALOGOS DE ELLOS, COMPRENDE UN RESIDUO DE CISTEINA TIOL-ACTIVA Y AL MENOS DOS RESIDUOS DE AMINOACIDOS CARGADOS POSITIVAMENTE SITUADOS SOBRE (PERO NO NECESARIAMENTE ADYACENTES A ) EL LATERAL TERMINAL-N, SOBRE (PERO NO NECESARIAMENTE ADYACENTES A ) EL LATERAL TERMINAL-C O SOBRE (PERO NO NECESARIAMENTE ADYACENTES A ) AMBOS TERMINALES-C,-N DE LA CISTEINA TIOL-ACTIVA DE USO TERAPEUTICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919125024A GB9125024D0 (en) | 1991-11-25 | 1991-11-25 | Rheumatoid arthritus treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2112921T3 true ES2112921T3 (es) | 1998-04-16 |
Family
ID=10705197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92923909T Expired - Lifetime ES2112921T3 (es) | 1991-11-25 | 1992-11-25 | Peptidos y anticuerpos para el tratamiento de la artritis reumatoide. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0614464B1 (es) |
JP (1) | JPH07507045A (es) |
AT (1) | ATE163939T1 (es) |
AU (2) | AU2951392A (es) |
CA (1) | CA2123694A1 (es) |
DE (1) | DE69224750D1 (es) |
ES (1) | ES2112921T3 (es) |
FI (1) | FI942392A0 (es) |
GB (2) | GB9125024D0 (es) |
WO (1) | WO1993011153A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9416865D0 (en) * | 1994-08-19 | 1994-10-12 | Peptide Therapeutrics Limited | Treatment of inflammatory diseases of the gastro-intestinal tract |
GB9416864D0 (en) * | 1994-08-19 | 1994-10-12 | Peptide Therapeutrics Limited | Treatment of IgA nephropathy |
SK284856B6 (sk) | 1996-03-01 | 2006-01-05 | Novartis Ag | Imunogénna molekula, farmaceutická kompozícia, ligand, spôsob prípravy imunogénnej molekuly a jej použitie |
AU2001270098A1 (en) * | 2000-06-22 | 2002-01-02 | San Diego State University Foundation | Recombination modulators and methods for their production and use |
EP2671891A3 (en) | 2008-06-27 | 2014-03-05 | Amgen Inc. | Ang-2 inhibition to treat multiple sclerosis |
US11918624B2 (en) | 2020-06-10 | 2024-03-05 | Kelsius Laboratories LLC | Therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2938420A1 (de) * | 1979-09-22 | 1981-04-09 | Hoechst Ag, 6000 Frankfurt | Neue peptide und verfahren zu ihrer herstellung |
AU572173B2 (en) * | 1983-08-29 | 1988-05-05 | Institut De Recherches Cliniques De Montreal | Natriuretic factors |
US4701416A (en) * | 1983-12-09 | 1987-10-20 | Cetus Corporation | Feline leukemia virus vaccine plasmids for fusion protein of the gp70 envelope protein of FELV |
US4692511A (en) * | 1984-07-03 | 1987-09-08 | Immunetech Pharmaceuticals | Peptide antagonists for the C5a anaphylatoxin |
EP0235391B1 (en) * | 1985-12-26 | 1992-06-10 | The University of Saskatchewan | Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses |
GB8616174D0 (en) * | 1986-07-02 | 1986-08-06 | Antibody Technology Ltd | Monoclonal antibodies |
DK268889A (da) * | 1988-06-07 | 1989-12-08 | Smithkline Beckman Corp | Cykliske d-cys6-peptidforbindelser, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse |
DE346022T1 (de) * | 1988-06-10 | 1990-05-23 | Medical Research Council, London, Gb | Peptidfragmente von hiv. |
FR2646425B1 (fr) * | 1989-04-26 | 1991-08-30 | Neosystem Sa | Peptides synthetiques du conjugue de l'ubiquitine et de l'histone h2a |
EP1475442A3 (en) * | 1989-05-08 | 2004-11-17 | Idexx Laboratories, Inc. | Polypeptides of feline T-cell lymphotropic lentivirus |
WO1991019001A1 (en) * | 1990-05-25 | 1991-12-12 | British Technology Group Ltd | Immunodiagnostic assay for rheumatoid arthritis |
CA2060699A1 (en) * | 1991-02-11 | 1992-08-12 | Isia Bursuker | Gm-csf inhibiting oligopeptides |
-
1991
- 1991-11-25 GB GB919125024A patent/GB9125024D0/en active Pending
-
1992
- 1992-11-25 DE DE69224750T patent/DE69224750D1/de not_active Expired - Lifetime
- 1992-11-25 ES ES92923909T patent/ES2112921T3/es not_active Expired - Lifetime
- 1992-11-25 AU AU29513/92A patent/AU2951392A/en not_active Abandoned
- 1992-11-25 GB GB9224684A patent/GB2261665B/en not_active Expired - Lifetime
- 1992-11-25 JP JP5509929A patent/JPH07507045A/ja active Pending
- 1992-11-25 EP EP92923909A patent/EP0614464B1/en not_active Expired - Lifetime
- 1992-11-25 AT AT92923909T patent/ATE163939T1/de not_active IP Right Cessation
- 1992-11-25 WO PCT/GB1992/002174 patent/WO1993011153A1/en active IP Right Grant
- 1992-11-25 CA CA002123694A patent/CA2123694A1/en not_active Abandoned
-
1994
- 1994-05-24 FI FI942392A patent/FI942392A0/fi unknown
-
1996
- 1996-11-25 AU AU71965/96A patent/AU7196596A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2951392A (en) | 1993-06-28 |
AU7196596A (en) | 1997-02-06 |
GB9224684D0 (en) | 1993-01-13 |
JPH07507045A (ja) | 1995-08-03 |
DE69224750D1 (de) | 1998-04-16 |
FI942392A (fi) | 1994-05-24 |
EP0614464A1 (en) | 1994-09-14 |
GB2261665A (en) | 1993-05-26 |
EP0614464B1 (en) | 1998-03-11 |
FI942392A0 (fi) | 1994-05-24 |
WO1993011153A1 (en) | 1993-06-10 |
GB2261665B (en) | 1995-11-08 |
ATE163939T1 (de) | 1998-03-15 |
GB9125024D0 (en) | 1992-01-22 |
CA2123694A1 (en) | 1993-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE442159T1 (de) | Parathyroidhormon analoge | |
ATE402957T1 (de) | Analoge des menschlichen interferon-alpha mit niedriger toxizität | |
CO4890856A1 (es) | CICATRIZACION DE FRACTURAS USANDO ANALOGOS DE PTHrP | |
ATE168719T1 (de) | Osteogene peptide | |
ES2174770T1 (es) | Peptidos diseñados para el diagnostico y el tratamiento de artritis reumatoide. | |
DK156592A (da) | Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin | |
ES548617A0 (es) | Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo | |
BR9306272A (pt) | Peptídeo e composiçao farmacêutica | |
ES2112921T3 (es) | Peptidos y anticuerpos para el tratamiento de la artritis reumatoide. | |
ES2094160T3 (es) | Peptidos terapeuticos, en particular analogos del peptido substancia p. | |
NO941415D0 (no) | Polypeptider og deres anvendelse for å nöytralisere antistoffer | |
DE69027542T2 (de) | Solubilisierung und reinigung des rezeptors für das gastrin-freisetzende peptid | |
DK34590A (da) | Biologisk aktive molekyler | |
PE20000931A1 (es) | Nuevos peptidos para uso en la inmunoterapia de enfermedades autoinmunes | |
TR199901831T2 (xx) | Kollagen-II'ye �zg� bir T-h�cresi epitopundan olu�an peptitler. | |
ES2114004T3 (es) | Procedimiento de preparacion de peptidos con un residuo prolina amidado en la posicion c-terminal. | |
SE9100284D0 (sv) | Novel peptide | |
ES2112311T3 (es) | Vacuna acelular. | |
DK0423326T3 (da) | Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta | |
DK119391A (da) | Humaninsulinanaloger |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 614464 Country of ref document: ES |